VENTRICULAR ASSIST DEVICE AND RELATED COMPUTER PROGRAM PRODUCT

Information

  • Patent Application
  • 20080045779
  • Publication Number
    20080045779
  • Date Filed
    July 18, 2007
    17 years ago
  • Date Published
    February 21, 2008
    16 years ago
Abstract
A cardiac ventricular assist device or VAD includes a pumping unit with a variable-volume chamber capable of receiving a mass of blood, and a control unit to control the pumping unit to obtain contraction of the variable-volume chamber, with consequent expulsion of the blood collected in the chamber, and expansion of the variable-volume chamber consequent on the flow of blood into the chamber. A flow line is included, such as a transcutaneous line, for a gaseous flow caused by the contraction and expansion of the variable-volume chamber. A sensor sensitive to the gaseous flow in the flow line generates a flow-meter signal that is indicative of the expulsion and inflow of blood with regard to the variable-volume chamber. The control unit is sensitive to said flow-meter signal and utilises that signal to control the pumping unit, for example to cause the pumping unit to operate in a condition of synchronous counterpulsation with regard to the natural heart, that is with the variable-volume chamber capable of receiving blood from the assisted heart when it is in a systolic phase and the variable-volume chamber that expels the blood collected in the chamber, when the assisted heart is in a diastolic phase.
Description

BRIEF DESCRIPTION OF THE DRAWINGS

The invention will now be described, as a simple example and without limiting intent, with reference to the attached drawings, in which:



FIGS. 1-3 have already been described,



FIG. 4 illustrates, in diagram form, with direct reference to the diagram in FIG. 1, a possible embodiment of the solution described here,



FIG. 5 is a time chart representative of the functioning of the solution described here, and



FIG. 6 comprises two time charts that are further representative of the functioning of the solution described here.





DETAILED DESCRIPTION OF EXAMPLES OF EMBODIMENTS OF THE INVENTION

Although the present description makes reference to a VAD with electromechanical operation, those of skill in the art will immediately appreciate that the invention applies in general also to VADs with different actuation systems, such as those to which reference was made in the introductory part of this description.


Indeed, the present invention principally concentrates on the alternating gaseous flow that occurs in the conduit 7, which—as was described above—is produced, and thus is caused, by the contraction and expansion movements of the pumping sac, regardless of the ways and means adopted to produce the contraction movement and enable expansion of the variable-volume chamber comprising the sac 3.


The proposed solution, similarly to known solutions developed for the systems Novacor and HeartMate described above, is based on detecting the filling of the blood sac 3 of the VAD. This detection is not however achieved directly through sensors applied inside the blood pump, on the sac itself or on the actuator, but rather indirectly by measuring the flow of air coming out, through the conduit 7, from the casing 2 of the VAD to compensate for the reduction in free volume inside it caused by the filling of the sac with blood.


As is represented in diagram form in FIG. 4 (where parts and elements equal or equivalent to those already described with reference to FIG. 1 are indicated with the same numbers) measurement of said flow of air is achieved through a sensor 10 associated to the conduit 7.


The sensor 10 is thus capable of generating a signal that is indicative of the flow in the conduit 7 and thus of the cyclic inflow and expulsion of blood into and out of the sac/variable-volume chamber, that is in practice, of the functioning of the VAD as a pumping device. In particular, the gaseous flow leaving the conduit 7 is indicative of the filling of the sac 3 of the VAD and thus of the ejection of blood from the left ventricle of the heart, that is of its systole.


Typically, the sensor 10 generates a signal indicative of the rate of flow (volume per unit time) or of the speed of flow of the gaseous matter in the conduit 7 and consequently indicative of the flow of blood ejected from the left ventricle of the heart towards the flexible sac 3 of the VAD.


The sensor 10 may consist of a flow meter of known type, such as a flow meter for gases or a device comprising a pressure transducer (for example piezoelectric) situated upstream of a constriction or fluid resistance.


For example, the flow meter 10, whose output signal is provided to the electronic unit (controller) 8 that supervises operation of the VAD 1 overall, may to advantage consist of the flow meter produced by the company Honeywell and available on the market under the code number AWM43600V. It may if desired be mounted in parallel to a small bypass conduit useful to adapt the interval of flow characteristic of the commercial flow meter to that of interest for the specific application (for example between 0 and 40 litres/minute).


It will be appreciated that the sensor 10 lends itself to being situated external to the blood pump (connected to the circulatory system and if desired implantable inside the human body), associating it in very diverse manners, for example introducing the sensor 10 into the conduit 7 or integrating it into the filter unit 9 (FIG. 2). Again, the sensor 10 might comprise one or more probes associated to the conduit 7 to detect the gaseous flow through it with a sensor module proper situated in a remote position with regard to the conduit 7: it is thus clear that the modalities and criteria to “associate” or “couple” the sensor 10 to the conduit 7 may be of the most diverse.


In any case, the most critical part of the VAD system, the pump, is not needlessly made more complex by the addition of the sensor or sensors needed for its operation in the “synchronous counterpulsation” modality and at the same time these sensors, here represented by the sensor 10, are situated in positions easily reachable for any replacement or repair action.


Measurement of the flow of air leaving the conduit 7, see curve F in FIG. 5, confirms that its time trend closely reproduces from the qualitative standpoint the trend of the flow of blood filling the sac 3 of the VAD.


This signal may be acquired and processed with simple techniques, of themselves known, by the electronic control unit 8, which is therefore capable of commanding the pumping unit 3-6 in function of the signal generated by the sensor 10. Just as it is incidentally clear to technicians who are experts in the sector, that in stating that the electronically controlled unit 8 is capable of commanding the pumping unit 3-6 as a function of the signal generated by the sensor 10 it is not in any way intended to imply that control of the pumping unit is only carried out as a function of the signal of the sensor 10: in reality, the unit 8 receives the flow signal from the sensor 10 and utilises that signal to control the functioning of the pumping unit 3-6, together with other parameters/signals available to the unit 8. For example, in the case of actuators operated by an electric motor, the electronic control unit 8 generally has available to it signals relating to the motion of the motor 6 and/or of the pusher plate 5 provided by specific encoders.


This situation may easily be verified in a VAD 1 of the type described here by observing the fact that, other conditions being equal, the device behaves in a different way, that is the unit 8 commands the pumping unit 3-6 in a different manner, depending upon whether the sensor 10 is connected or is not connected to the unit 8.


For example, the unit 8 may detect the maximum MF in the curve of the flow leaving the conduit 7 and wait for the flow to drop below a threshold T, defined as a given percentage fraction of the maximum flow MF, substantially corresponding to the end of the filling peak of the sac 3 and thus to the end of the systole of the natural heart. The electronic control unit 8 may at that instant command the actuator 6 such as to start a cycle of movement of the pressure plate 5, such as that illustrated in FIG. 5 by curve D: compression of the sac (ejection of blood from the VAD to the aorta) and return to the retracted position (sac free to fill again) in expectation of the start of the subsequent cycle.


It must be stressed that, in general, analysis of the flow signal may be performed on the basis of the shape of said signal without the need to have available absolute values of the gaseous flow measured. This leads to intrinsic system safety since it makes the control system independent of any variations in sensitivity of the flow meter consequent on changes in temperature or on ageing.


For further reference, the scale of the abscissa in FIG. 5 is a time scale quoted in seconds in which, as well as the values already mentioned above, the following are indicated:


with I, the instant at which the flow drops below the threshold T defined above and at which the control unit 8 commands the start of the movement of the pusher plate 5 aimed at producing contraction of the sac 3,


with II, the instant at which the VAD begins ejection (crossover point of zero flow in the conduit detected by the sensor 10),


with III, the interval of ejection of the VAD, and


with IV, the amplitude of the movement squeezing the sac 3 by the pusher plate 5 (representative in practice of the charge of blood delivered) after contact with the sac 3.


It will be appreciated that the instants I and II do not coincide. Indeed, it is usual to operate such that (according to known criteria) in the release movement of the sac 3 that leads the sac 3 to fill with blood, the pusher plate 5 disengages from the wall of the sac in order to leave the sac 3 completely free to expand and receive blood. In consequence, in commanding contraction of the sac, the pusher plate 5 must initially make a brief movement to regain contact with the sac 3 and to begin ejection. From observation of this fact it appears that, in an independent manner from any other consideration, the action of monitoring the gaseous flow in the conduit (percutaneous line) 7, achieved through the sensor 10, also makes it possible to detect the movement of expulsion of the blood with regard to the sac 3 in a much more precise and faithful fashion than could be done, for example, by monitoring movement of the pusher plate 5. This precisely because the gaseous flow in the conduit 7 is caused by the contraction/expansion of the sac 3 which acts as a flexible pumping chamber for the blood.


Other control logics are naturally possible; it is for example possible to detect the start of the systole of the natural ventricle in correspondence with the maximum slope of the rising part of the air flow leaving the conduit 7, and control operation of the VAD starting from detection of this instant, which is closely correlated, in the cardiac cycle, to the start of the systole.


The signal corresponding to the air flow leaving the conduit 7 is appropriate to be acquired and processed by the electronic unit 8 of the VAD in such a manner as to control operation of the VAD in a synchronous manner and in counterpulsation with the heart. This result conforms to what is illustrated in FIG. 3 (central curve: VAD On-synchronous). In particular, the above-mentioned signal of cardiac rhythm indicative of the systolic and diastolic phases of the heart C assisted by the device 1 is provided by the sensor 10 sensitive to the gaseous flow in the conduit 7.


In programming the electronic unit 8 that controls the VAD, as was said above, an operational cycle is defined that comprises, for example:


compression of the sac (ejection of blood by the VAD),


return to the retracted position (sac free to fill again),


wait to detect the end of a subsequent cardiac systole before starting the next cycle.


In programming the electronic unit 8, a maximum value may be set for the above wait time. In this case, should no systole be detected, due to a period of cardiac asystolia or a malfunctioning of the flow sensor 10, the VAD 1 is activated at a fixed frequency. This ensures that the system operates in a condition of safety, without allowing cardiocirculatory assistance to lack, either in the case of an irregular cardiac cycle or in the case of malfunctioning of the cycle detection system. Should the cause of a failure to detect the cardiac systole be an arrhythmia (such as for example an asystolia) followed by a return to a regular cardiac rhythm, the system to detect and process the air flow leaving the conduit 7 enables the control unit 8 to become aware of the return to a regular rhythm and to re-synchronise operation of the VAD with the heart beat.


This is illustrated in FIG. 6, in which in the upper curve a possible trend is shown as a function of time (scale on the abscissa, in seconds) of the air flow signal (here, too, indicated with F, ordinate scale, indicated in arbitrary units). In the lower curve, on the contrary, a possible coordinated time trend is shown (same scale on the abscissa) of movement of the pusher plate 5 (here too indicated with D, ordinate scale, in hundredths of a millimetre) of the VAD 1 commanded by the electronic control unit 8 in the case of an asystolia of the duration of approximately 5 heart beats.


It may be noted that, during the asystolia, the VAD is activated at a fixed frequency (movement of the pusher plate with long and constant wait times) whereas on return to the regular cardiac rhythm, operation of the VAD, during a small number of cycles, returns to being synchronous and in counterpulsation.


Naturally, without prejudice to the underlying principles of the invention, construction details and embodiments may vary, even significantly, with regard to what is described here as a simple example without limiting intent, without thereby departing from the scope of the invention, as defined by the attached claims.

Claims
  • 1. A cardiac ventricular assistance device comprising: a pumping unit with a variable-volume chamber situated inside a casing and capable of receiving a mass of blood,a control unit to obtain, through said pumping unit: i) contraction of said variable-volume chamber, with consequent expulsion of the blood collected in the chamber andii) expansion of said variable-volume chamber, with consequent inflow of blood into the chamber, anda gaseous flow line to permit gaseous inflow and outflow with regard to said casing as a result of contraction and expansion of said variable-volume chamber,a sensor to monitor the gaseous flow in said flow line to generate a flow-meter signal that, being indicative of the gaseous flow in said flow line, is indicative of the inflow and expulsion of blood with regard to said variable-volume chamber, andsaid control unit coupled to said sensor and receiving said flow-meter signal from said sensor, said control unit configured to utilize said flow-meter signal and to control said pumping unit based on said flow-meter signal.
  • 2. The device according to claim 1, wherein said gaseous flow line is a transcutaneous line.
  • 3. The device according to claim 1, wherein said sensor is situated along or within said flow line.
  • 4. The device according to claim 1, wherein said flow line includes or terminates in a filter unit and said sensor is situated in said filter unit.
  • 5. The device according to claim 1, wherein said control unit: receives and is configured to utilize a cardiac rhythm signal indicative of the systolic and diastolic phases of a heart assisted by the device to control said pumping unit, andis configured to control said pumping unit in a condition of synchronous counterpulsation, with said variable-volume chamber configured to receive blood from said assisted heart when said assisted heart is in systolic phase and with said variable-volume chamber that expels the blood collected in the chamber when said assisted heart is in diastolic phase.
  • 6. The device according to claim 5, wherein said cardiac rhythm signal indicative of the systolic and diastolic phases of the heart assisted by the device is achieved by said flow-meter signal generated by said sensor sensitive to the gaseous flow in said flow line.
  • 7. The device according to claim 1 wherein said control unit is configured to detect the passage of said flow-meter signal below a threshold indicative of the end of blood flow into said variable-volume chamber and at said passage to command the start of a cycle comprising the contraction of said variable-volume chamber, with consequent expulsion of the blood collected in the chamber, and the expansion of the variable-volume chamber, with consequent inflow of blood into the chamber.
  • 8. The device according to claim 7, wherein said control unit is configured to determine said threshold as a given fraction of the maximum flow of said flow-meter signal.
  • 9. The device according to claim 1, wherein said control unit is configured to detect the start of the systole of the heart assisted by the device in correspondence with the maximum slope of the rising part of said flow-meter signal and control operation of the device starting from the beginning of the systole thus detected.
  • 10. The device according to claim 1, wherein said control unit is configured to control the device according to cycles, the cycles comprising: a contraction of said variable-volume chamber, with consequent expulsion of the blood collected in the chamber,an expansion of said variable-volume chamber, with consequent inflow of blood into the chamber, anda wait to detect the end of a subsequent systolic phase of the heart assisted by the device before starting the successive cycles.
  • 11. The device according to claim 10, wherein said control unit is configured to set a maximum value for said wait time to detect the end or the start of a successive systole of the heart assisted by the device.
  • 12. The device according to claim 1, wherein said control unit is configured to control said pumping unit with fixed pumping frequency in the presence of an event chosen from a group consisting of: failure to detect a systole of the heart assisted by the device, andabsence of said flow-meter signal.
  • 13. A computer program product loadable into the memory of computer and including software code portions that, when the product is run on a computer, commands the operation of said computer in such a way that said computer acts as said control unit of the device according to claim 1.
  • 14. The device according to claim 2, wherein said sensor is situated along or within said flow line.
  • 15. The device according to claim 2, wherein said flow line includes or terminates in a filter unit and said sensor is situated in said filter unit.
Priority Claims (1)
Number Date Country Kind
06425592.0 Aug 2006 EP regional